Antimicrobials, a broad category of medications, play a pivotal role in combating various microorganisms, including bacteria, viruses, fungi, and parasites. Antibiotics, a subset of antimicrobials, specifically target bacteria, disrupting their growth or causing their demise. Common antibiotics like penicillins, cephalosporins, and tetracyclines have revolutionized medicine, transforming the landscape of infectious disease treatment. Antivirals, another subgroup, focus on viral infections, inhibiting viral replication or entry into host cells. Medications such as oseltamivir (Tamiflu) for influenza exemplify the antiviral class. Antifungals combat fungal infections, and antiparasitics target parasitic organisms, collectively contributing to the comprehensive field of antimicrobial therapeutics. However, the emergence of drug-resistant strains poses a global health threat, necessitating the development of novel antimicrobials, enhanced diagnostics, and robust stewardship programs to optimize their use and mitigate resistance.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation